Inventor · disambiguated record
Roberto Mallone
Also filed as: MALLONE ROBERTO
6 granted patents·7 pending applications·5 citations·filing 2010–2024
71Inventor score
Files withINST NAT SANTE RECH MED8INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE2INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)1MALLONE ROBERTO1UNI DEGLI STUDI DI SASSARI1
Top patents by PatentIndex Score
13 records- 0171US11078251B2T cell receptors (TCR) and uses thereof for the diagnosis and treatment of diabetesINST NAT SANTE RECH MED·Filed 2016·Granted Aug 3, 2021·2 cites·1 claims
- 0270US9708583B2Methods for stimulating antigen-specific T cell responsesINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2014·Granted Jul 18, 2017·2 cites·13 claims
- 0367US2025084143A1Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetesINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0460US2020155658A1Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with fc-coupled antigensINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0559US9091679B2Method for stimulating antigen-specific T cell responses using accelerated co-cultured dendritic cellsMALLONE ROBERTO·Filed 2010·Granted Jul 28, 2015·1 cites·20 claims
- 0659US2022175896A1Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with fc-coupled antigensINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0754US12098179B2Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetesINST NAT SANTE RECH MED·Filed 2019·Granted Sep 24, 2024·0 cites·7 claims
- 0854US10507234B2Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigensINST NAT SANTE RECH MED·Filed 2016·Granted Dec 17, 2019·0 cites·13 claims
- 0945US12492230B2Antigenic peptides deriving from secretogranin V and uses thereof for the diagnosis and treatment of type 1 diabetesINST NAT SANTE RECH MED·Filed 2019·Granted Dec 9, 2025·0 cites·18 claims
- 1039US2021023209A1Antigenic peptides deriving from pcsk2 and uses thereof for the diagnosis and treatment of type 1 diabetesINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1138US2014271701A1Use of mycobacterium avium paratuberculosis peptides to diagnose type 1 diabetesUNI DEGLI STUDI DI SASSARI·Filed 2012·Application pending·0 cites
- 1235US2017072032A1Prenatal therapy to induce immune toleranceINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2016·Application pending·0 cites
- 1333US2016341718A1Methods for testing t cell priming efficacy in a subjectINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roberto Mallone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →